15 results on '"Gulley, James L."'
Search Results
2. Avelumab: is it time to get excited?
3. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy.
4. Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers.
5. Prospects for the future of prostate cancer vaccines.
6. Randomized phase II trial of docetaxel with or without PSA-TRICOM vaccine in patients with castrate-resistant metastatic prostate cancer: A trial of the ECOG-ACRIN cancer research group (E1809).
7. Adding fuel to the fire: Immunogenic intensification.
8. Effects of conventional therapeutic interventions on the number and function of regulatory T cells.
9. Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents.
10. Therapeutic vaccines.
11. The role of soluble CD40L in immunosuppression.
12. A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells.
13. TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer.
14. Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm.
15. Poxviral-based vaccine elicits immunologic responses in prostate cancer patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.